Ferrucci V, Lomada S, Wieland T, Zollo M
Cancer Metastasis Rev. 2024; 43(2):755-775.
PMID: 38180572
PMC: 11156750.
DOI: 10.1007/s10555-023-10165-4.
Prunier C, Chavrier P, Boissan M
Cancer Metastasis Rev. 2023; 42(4):1155-1167.
PMID: 37353690
PMC: 10713741.
DOI: 10.1007/s10555-023-10118-x.
Matyasi B, Petovari G, Danko T, Butz H, Liko I, Low P
Cancers (Basel). 2022; 14(16).
PMID: 36010906
PMC: 9406105.
DOI: 10.3390/cancers14163913.
Pennino F, Murakami M, Zollo M, Robertson E
Oncogenesis. 2021; 10(4):34.
PMID: 33931587
PMC: 8087825.
DOI: 10.1038/s41389-021-00326-x.
Kim B, Lee K
Exp Mol Med. 2021; 53(3):346-357.
PMID: 33753879
PMC: 8080780.
DOI: 10.1038/s12276-021-00575-1.
CTCF and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1.
Wong K, Song J, Wong Y
Sci Rep. 2021; 11(1):491.
PMID: 33436746
PMC: 7804126.
DOI: 10.1038/s41598-020-79869-9.
Structure, Folding and Stability of Nucleoside Diphosphate Kinases.
Georgescauld F, Song Y, Dautant A
Int J Mol Sci. 2020; 21(18).
PMID: 32947863
PMC: 7554756.
DOI: 10.3390/ijms21186779.
The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis.
Adam K, Lesperance J, Hunter T, Zage P
Int J Mol Sci. 2020; 21(9).
PMID: 32392889
PMC: 7247550.
DOI: 10.3390/ijms21093319.
The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis.
Matyasi B, Farkas Z, Kopper L, Sebestyen A, Boissan M, Mehta A
Pathol Oncol Res. 2020; 26(1):49-61.
PMID: 31993913
PMC: 7109179.
DOI: 10.1007/s12253-020-00797-0.
Extracellular NME proteins: a player or a bystander?.
Romani P, Ignesti M, Gargiulo G, Hsu T, Cavaliere V
Lab Invest. 2017; 98(2):248-257.
PMID: 29035383
DOI: 10.1038/labinvest.2017.102.
NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.
Tan C, Chang C
Lab Invest. 2017; 98(2):219-227.
PMID: 28991262
DOI: 10.1038/labinvest.2017.105.
Nucleoside diphosphate kinases (NDPKs) in animal development.
Takacs-Vellai K, Vellai T, Farkas Z, Mehta A
Cell Mol Life Sci. 2014; 72(8):1447-62.
PMID: 25537302
PMC: 11113130.
DOI: 10.1007/s00018-014-1803-0.
Regulatory functions of Nm23-H2 in tumorigenesis: insights from biochemical to clinical perspectives.
Li Y, Tong Y, Wong Y
Naunyn Schmiedebergs Arch Pharmacol. 2014; 388(2):243-56.
PMID: 25413836
DOI: 10.1007/s00210-014-1066-1.
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007.
Miller K, Althouse S, Nabell L, Rugo H, Carey L, Kimmick G
Breast Cancer Res Treat. 2014; 148(1):99-106.
PMID: 25257727
PMC: 8374454.
DOI: 10.1007/s10549-014-3131-3.
MUC1* ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naïve state.
Smagghe B, Stewart A, Carter M, Shelton L, Bernier K, Hartman E
PLoS One. 2013; 8(3):e58601.
PMID: 23505541
PMC: 3591366.
DOI: 10.1371/journal.pone.0058601.
AMPK directly inhibits NDPK through a phosphoserine switch to maintain cellular homeostasis.
Onyenwoke R, Forsberg L, Liu L, Williams T, Alzate O, Brenman J
Mol Biol Cell. 2011; 23(2):381-9.
PMID: 22114351
PMC: 3258181.
DOI: 10.1091/mbc.E11-08-0699.
Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic viruses.
Saha A, Robertson E
FEBS Lett. 2011; 585(20):3174-84.
PMID: 21846466
PMC: 4289605.
DOI: 10.1016/j.febslet.2011.08.007.
Learning about the functions of NME/NM23: lessons from knockout mice to silencing strategies.
Boissan M, Lacombe M
Naunyn Schmiedebergs Arch Pharmacol. 2011; 384(4-5):421-31.
PMID: 21562815
DOI: 10.1007/s00210-011-0649-3.
Aggregation of the neuroblastoma-associated mutant (S120G) of the human nucleoside diphosphate kinase-A/NM23-H1 into amyloid fibrils.
Georgescauld F, Sabate R, Espargaro A, Ventura S, Chaignepain S, Lacombe M
Naunyn Schmiedebergs Arch Pharmacol. 2011; 384(4-5):373-81.
PMID: 21484438
DOI: 10.1007/s00210-011-0628-8.
A genetic interaction between NDPK and AMPK in Dictyostelium discoideum that affects motility, growth and development.
Annesley S, Bago R, Mehta A, Fisher P
Naunyn Schmiedebergs Arch Pharmacol. 2011; 384(4-5):341-9.
PMID: 21374069
PMC: 3390704.
DOI: 10.1007/s00210-011-0615-0.
